Impact of fibromyalgia pain on health-related quality of life before and after treatment with tramadol/acetaminophen

Robert (Rob) Bennett, Jeff Schein, Mark R. Kosinski, David J. Hewitt, Donna M. Jordan, Norman R. Rosenthal

    Research output: Contribution to journalArticle

    114 Citations (Scopus)

    Abstract

    Objective. To assess health-related quality of life (HRQOL) in patients with moderate-to-severe fibromyalgia pain compared with the general population, and to assess the relationship between pain severity and HRQOL before and after treatment with an analgesic. Methods. Data were obtained from a randomized, double-blind study of patients with moderate-to-severe fibromyalgia pain. Patients received either tramadol/acetaminophen or placebo 4 times/day as needed for 91 days. HRQOL was measured with the Short Form 36 Health Survey (SF-36) and the Fibromyalgia Impact Questionnaire (FIQ). Baseline HRQOL scores were compared with a national sample of noninstitutionalized adults and a sample of patients with impaired HRQOL due to congestive heart failure. Patients with fibromyalgia were divided into tertiles by change in pain severity, and SF-36 scores were compared across the tertiles. Mean changes in SF-36 and FIQ scores were compared between treatment groups. Results. Patients with fibromyalgia scored lower than the US norm on all SF-36 scales (P <0.0001) and lower than patients with congestive heart failure on most scales. More severe pain was associated with greater impairment of HRQOL compared with less severe pain (P <0.0001). Patients in the highest tertile for improved pain severity had greater improvement in HRQOL scores than patients in the lower tertiles. Compared with patients who received placebo (n = 157), patients treated with tramadol/acetaminophen (n = 156) showed greater improvement on SF-36 physical functioning, role physical, bodily pain, and physical summary scales, as well as FIQ scales for ability to do job, pain, and stiffness (P <0.01). Conclusion. Moderate-to-severe fibromyalgia pain significantly impairs HRQOL, and effective pain relief in these patients significantly increases HRQOL.

    Original languageEnglish (US)
    Pages (from-to)519-527
    Number of pages9
    JournalArthritis Care and Research
    Volume53
    Issue number4
    DOIs
    StatePublished - Aug 15 2005

    Fingerprint

    Tramadol
    Fibromyalgia
    Acetaminophen
    Quality of Life
    Pain
    Therapeutics
    Heart Failure
    Placebos
    Aptitude
    Health Surveys
    Double-Blind Method
    Analgesics

    Keywords

    • Acetaminophen
    • Fibromyalgia
    • Pain
    • Quality of life
    • Tramadol

    ASJC Scopus subject areas

    • Rheumatology

    Cite this

    Bennett, R. R., Schein, J., Kosinski, M. R., Hewitt, D. J., Jordan, D. M., & Rosenthal, N. R. (2005). Impact of fibromyalgia pain on health-related quality of life before and after treatment with tramadol/acetaminophen. Arthritis Care and Research, 53(4), 519-527. https://doi.org/10.1002/art.21319

    Impact of fibromyalgia pain on health-related quality of life before and after treatment with tramadol/acetaminophen. / Bennett, Robert (Rob); Schein, Jeff; Kosinski, Mark R.; Hewitt, David J.; Jordan, Donna M.; Rosenthal, Norman R.

    In: Arthritis Care and Research, Vol. 53, No. 4, 15.08.2005, p. 519-527.

    Research output: Contribution to journalArticle

    Bennett, RR, Schein, J, Kosinski, MR, Hewitt, DJ, Jordan, DM & Rosenthal, NR 2005, 'Impact of fibromyalgia pain on health-related quality of life before and after treatment with tramadol/acetaminophen', Arthritis Care and Research, vol. 53, no. 4, pp. 519-527. https://doi.org/10.1002/art.21319
    Bennett, Robert (Rob) ; Schein, Jeff ; Kosinski, Mark R. ; Hewitt, David J. ; Jordan, Donna M. ; Rosenthal, Norman R. / Impact of fibromyalgia pain on health-related quality of life before and after treatment with tramadol/acetaminophen. In: Arthritis Care and Research. 2005 ; Vol. 53, No. 4. pp. 519-527.
    @article{af4aefefd615474ab84302fb316f66ff,
    title = "Impact of fibromyalgia pain on health-related quality of life before and after treatment with tramadol/acetaminophen",
    abstract = "Objective. To assess health-related quality of life (HRQOL) in patients with moderate-to-severe fibromyalgia pain compared with the general population, and to assess the relationship between pain severity and HRQOL before and after treatment with an analgesic. Methods. Data were obtained from a randomized, double-blind study of patients with moderate-to-severe fibromyalgia pain. Patients received either tramadol/acetaminophen or placebo 4 times/day as needed for 91 days. HRQOL was measured with the Short Form 36 Health Survey (SF-36) and the Fibromyalgia Impact Questionnaire (FIQ). Baseline HRQOL scores were compared with a national sample of noninstitutionalized adults and a sample of patients with impaired HRQOL due to congestive heart failure. Patients with fibromyalgia were divided into tertiles by change in pain severity, and SF-36 scores were compared across the tertiles. Mean changes in SF-36 and FIQ scores were compared between treatment groups. Results. Patients with fibromyalgia scored lower than the US norm on all SF-36 scales (P <0.0001) and lower than patients with congestive heart failure on most scales. More severe pain was associated with greater impairment of HRQOL compared with less severe pain (P <0.0001). Patients in the highest tertile for improved pain severity had greater improvement in HRQOL scores than patients in the lower tertiles. Compared with patients who received placebo (n = 157), patients treated with tramadol/acetaminophen (n = 156) showed greater improvement on SF-36 physical functioning, role physical, bodily pain, and physical summary scales, as well as FIQ scales for ability to do job, pain, and stiffness (P <0.01). Conclusion. Moderate-to-severe fibromyalgia pain significantly impairs HRQOL, and effective pain relief in these patients significantly increases HRQOL.",
    keywords = "Acetaminophen, Fibromyalgia, Pain, Quality of life, Tramadol",
    author = "Bennett, {Robert (Rob)} and Jeff Schein and Kosinski, {Mark R.} and Hewitt, {David J.} and Jordan, {Donna M.} and Rosenthal, {Norman R.}",
    year = "2005",
    month = "8",
    day = "15",
    doi = "10.1002/art.21319",
    language = "English (US)",
    volume = "53",
    pages = "519--527",
    journal = "Arthritis and Rheumatology",
    issn = "2326-5191",
    publisher = "John Wiley and Sons Ltd",
    number = "4",

    }

    TY - JOUR

    T1 - Impact of fibromyalgia pain on health-related quality of life before and after treatment with tramadol/acetaminophen

    AU - Bennett, Robert (Rob)

    AU - Schein, Jeff

    AU - Kosinski, Mark R.

    AU - Hewitt, David J.

    AU - Jordan, Donna M.

    AU - Rosenthal, Norman R.

    PY - 2005/8/15

    Y1 - 2005/8/15

    N2 - Objective. To assess health-related quality of life (HRQOL) in patients with moderate-to-severe fibromyalgia pain compared with the general population, and to assess the relationship between pain severity and HRQOL before and after treatment with an analgesic. Methods. Data were obtained from a randomized, double-blind study of patients with moderate-to-severe fibromyalgia pain. Patients received either tramadol/acetaminophen or placebo 4 times/day as needed for 91 days. HRQOL was measured with the Short Form 36 Health Survey (SF-36) and the Fibromyalgia Impact Questionnaire (FIQ). Baseline HRQOL scores were compared with a national sample of noninstitutionalized adults and a sample of patients with impaired HRQOL due to congestive heart failure. Patients with fibromyalgia were divided into tertiles by change in pain severity, and SF-36 scores were compared across the tertiles. Mean changes in SF-36 and FIQ scores were compared between treatment groups. Results. Patients with fibromyalgia scored lower than the US norm on all SF-36 scales (P <0.0001) and lower than patients with congestive heart failure on most scales. More severe pain was associated with greater impairment of HRQOL compared with less severe pain (P <0.0001). Patients in the highest tertile for improved pain severity had greater improvement in HRQOL scores than patients in the lower tertiles. Compared with patients who received placebo (n = 157), patients treated with tramadol/acetaminophen (n = 156) showed greater improvement on SF-36 physical functioning, role physical, bodily pain, and physical summary scales, as well as FIQ scales for ability to do job, pain, and stiffness (P <0.01). Conclusion. Moderate-to-severe fibromyalgia pain significantly impairs HRQOL, and effective pain relief in these patients significantly increases HRQOL.

    AB - Objective. To assess health-related quality of life (HRQOL) in patients with moderate-to-severe fibromyalgia pain compared with the general population, and to assess the relationship between pain severity and HRQOL before and after treatment with an analgesic. Methods. Data were obtained from a randomized, double-blind study of patients with moderate-to-severe fibromyalgia pain. Patients received either tramadol/acetaminophen or placebo 4 times/day as needed for 91 days. HRQOL was measured with the Short Form 36 Health Survey (SF-36) and the Fibromyalgia Impact Questionnaire (FIQ). Baseline HRQOL scores were compared with a national sample of noninstitutionalized adults and a sample of patients with impaired HRQOL due to congestive heart failure. Patients with fibromyalgia were divided into tertiles by change in pain severity, and SF-36 scores were compared across the tertiles. Mean changes in SF-36 and FIQ scores were compared between treatment groups. Results. Patients with fibromyalgia scored lower than the US norm on all SF-36 scales (P <0.0001) and lower than patients with congestive heart failure on most scales. More severe pain was associated with greater impairment of HRQOL compared with less severe pain (P <0.0001). Patients in the highest tertile for improved pain severity had greater improvement in HRQOL scores than patients in the lower tertiles. Compared with patients who received placebo (n = 157), patients treated with tramadol/acetaminophen (n = 156) showed greater improvement on SF-36 physical functioning, role physical, bodily pain, and physical summary scales, as well as FIQ scales for ability to do job, pain, and stiffness (P <0.01). Conclusion. Moderate-to-severe fibromyalgia pain significantly impairs HRQOL, and effective pain relief in these patients significantly increases HRQOL.

    KW - Acetaminophen

    KW - Fibromyalgia

    KW - Pain

    KW - Quality of life

    KW - Tramadol

    UR - http://www.scopus.com/inward/record.url?scp=24644503080&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=24644503080&partnerID=8YFLogxK

    U2 - 10.1002/art.21319

    DO - 10.1002/art.21319

    M3 - Article

    C2 - 16082646

    AN - SCOPUS:24644503080

    VL - 53

    SP - 519

    EP - 527

    JO - Arthritis and Rheumatology

    JF - Arthritis and Rheumatology

    SN - 2326-5191

    IS - 4

    ER -